EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY-NC 4.0

The effect of severe renal impairment on the pharmacokinetics, safety and tolerability of mitiperstat

Chandrali S Bhattacharya, Patricia Ely Pizzato, Maria Heijer, Mikael Sunnåker iD, Julie Holden, Monika Trebski, Karin Nelander, Hodan Ali, Diyan K Genov, Malin Aurell, Anna Collén, Hans Ericsson iD

British Journal of Clinical Pharmacology · 2024

DOI: 10.1111/bcp.16205 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift British Journal of Clinical Pharmacology, 2024. Verfasst von Chandrali S Bhattacharya und 11 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD…. Hauptthemen laut MEDLINE: Peroxidase, Enzyme Inhibitors, Renal Insufficiency. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: AstraZeneca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Mitiperstat is a novel, highly potent myeloperoxidase inhibitor being evaluated in patients with cardio‐metabolic disease (phase 2). These patients often have impaired renal function, which may affect mitiperstat pharmacokinetics. This study assessed mitiperstat pharmacokinetics, safety and tolerability in participants with severe renal impairment and normal renal function, to inform inclusion of participants with estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73 m 2 in phase 3.

Methods

Participants with severe renal impairment (eGFR ≥15 and

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PeroxidaseEnzyme InhibitorsRenal InsufficiencyPharmacokineticsHumansMaleFemaleAdultMiddle AgedAgedBiomarkers, PharmacologicalDrug TolerancePyrimidinesPyrrolesAdministration, OralKidneyCardiovascular Diseases

Stichwörter der Autor:innen

AZD4831heart failurekidney diseasemitiperstatpharmacokineticsrenal impairment

Substanzen

AZD4831PeroxidaseEnzyme InhibitorsBiomarkers, PharmacologicalPyrimidinesPyrroles

Autor:innen und Institutionen

  • Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Early Clinical Development, Research and Early Clinical Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Integrated Bioanalysis, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden.
  • Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Patient Safety, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Biometrics, Late Cardiovascular Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.

ORCID-Profile: Mikael Sunnåker, Hans Ericsson

Förderung

  • AstraZeneca

Zitieren

APA

Bhattacharya, C. S., Pizzato, P. E., Heijer, M., Sunnåker, M., Holden, J., Trebski, M., Nelander, K., Ali, H., Genov, D. K., Aurell, M., Collén, A., & Ericsson, H. (2024). The effect of severe renal impairment on the pharmacokinetics, safety and tolerability of mitiperstat. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.16205

Vancouver

Bhattacharya CS, Pizzato PE, Heijer M, Sunnåker M, Holden J, Trebski M, et al. The effect of severe renal impairment on the pharmacokinetics, safety and tolerability of mitiperstat. British Journal of Clinical Pharmacology. 2024. doi:10.1111/bcp.16205

BibTeX
@article{Bhattacharya2024,
  author = {Bhattacharya, Chandrali S and Pizzato, Patricia Ely and Heijer, Maria and Sunnåker, Mikael and Holden, Julie and Trebski, Monika and Nelander, Karin and Ali, Hodan and Genov, Diyan K and Aurell, Malin and Collén, Anna and Ericsson, Hans},
  title = {The effect of severe renal impairment on the pharmacokinetics, safety and tolerability of mitiperstat},
  journal = {British Journal of Clinical Pharmacology},
  year = {2024},
  doi = {10.1111/bcp.16205}
}
Kostenlos starten →